A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulator.

Zaalberg A, Lacoste A, Minnee E, Mayayo-Peralta I, Schuurman K, Gregoricchio S, van Schaik TA, Hoekman L, Li D, Corey E, Janssen H, Lieftink C, Prekovic S, Proost N, van de Ven M, Zander S, Altelaar M, Nelson PS, Beijersbergen RL, Zwart W

Year

2026

Journal

Oncogene